Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCf10A cells

Molecular Pharmacology

Volumn 74, Issue 1, 2008, Pages 255-263

  Dong, Bin ^a   Matsumura, Fumio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ARACHIDONIC ACID; CYTOCHROME P450 1A1; METHYLARACHIDONYLFLUOROPHOSPHONATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST EPITHELIUM; CALCIUM SIGNALING; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

ARACHIDONIC ACID; ARACHIDONIC ACIDS; BORON COMPOUNDS; BREAST; CALCIUM CHANNEL BLOCKERS; CELL LINE, TRANSFORMED; EGTAZIC ACID; ENZYME ACTIVATION; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; HUMANS; NIFEDIPINE; PHOSPHOLIPASES A2, CYTOSOLIC; PHOSPHONIC ACIDS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TRANSFECTION;

EID: 45749119506     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.044669     Document Type: Article

References (36)

1. Alexander LD, Ding Y, Alagarsamy S, Cui XL, and Douglas JG (2006) Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor. Kidney Int 69:1823-1832.
2. Brown K, Park S, Kanno T, Franzoso G, and Siebenlist U (1993) Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci U S A 90:2532-2536.
3. Calogero RA, Cordero F, Forni G, and Cavallo F (2007) Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice. Breast Cancer Res 9:211.
4. Casibang M, Purdom S, Jakowlew S, Neckers L, Zia F, Ben-Av P, Hla T, You L, Jablons DM, and Moody TW (2001) Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells. Lung Cancer 31:203-212.
5. Davis JW Jr, Burdick AD, Lauer FT, and Burchiel SW (2003) The aryl hydrocarbon receptor antagonist, 3′methoxy-4′nitroflavone, attenuates 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent regulation of growth factor signaling and apoptosis in the MCF-10A cell line. Toxicol Appl Pharmacol 188:42-49.
6. Davis JW 2nd, Lauer FT, Burdick AD, Hudson LG, and Burchiel SW (2001) Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor alpha production. Cancer Res 61:3314-3320.
7. DeNardo DG and Coussens LM (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9:212.
8. Dunlap DY, Ikeda I, Nagashima H, Vogel CF, and Matsumura F (2002) Effects of src-deficiency on the expression of in vivo toxicity of TCDD in a strain of c-src knockout mice procured through six generations of backcrossings to C57BL/6 mice. Toxicology 172:125-141.
9. Fiorini S, Ferretti ME, Biondi C, Pavan B, Lunghi L, Paganetto G, and Abelli L (2003) 17Beta-eEstradiol stimulates arachidonate release from human amnionlike WISH cells through a rapid mechanism involving a membrane receptor. Endocrinology 144:3359-3367.
10. Fisher JM, Jones KW, and Whitlock JP, Jr. (1989) Activation of transcription as a general mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Mol Carcinog 1:216-221.
11. Fukunaga BN, Probst MR, Reisz-Porszasz S, and Hankinson O (1995) Identification of functional domains of the aryl hydrocarbon receptor. J Biol Chem 270:29270-29278.
12. Hankinson O (1995) The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340.
13. Hanneman WH, Legare ME, Barhoumi R, Burghardt RC, Safe S, and Tiffany-Castiglioni E (1996) Stimulation of calcium uptake in cultured rat hippocampal neurons by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 112:19-28.
14. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, and Rodan SB (1994) Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Investig 93:2490-2496.
15. Hiscox S, Morgan L, Green T, and Nicholson RI (2006) Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer. Endocrine-related cancer 13 (Suppl 1):S53-S59.
16. Karras JG, Morris DL, Matulka RA, Kramer CM, and Holsapple MP (1996) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion. Toxicol Appl Pharmacol 137:275-284.
17. Kim KH and Bender JR (2005) Rapid, estrogen receptor-mediated signaling: why is the endothelium so special? Sci STKE 2005:pe28.
18. Kitamura M and Kasai A (2007) Cigarette smoke as a trigger for the dioxin receptormediated signaling pathway. Cancer Lett 252:184-194.
19. Kitamura N, Wong P, and Matsumura F (2006) Mechanistic investigation on the cause for reduced toxicity of TCDD in wa-1 homozygous TGFalpha mutant strain of mice as compared its matching wild-type counterpart, C57BL/6J mice. J Biochem Mol Toxicol 20:151-158.
20. Mariussen E and Fonnum F (2006) Neurochemical targets and behavioral effects of organohalogen compounds: an update. Crit Rev Toxicol 36:253-289.
21. Martinez JM, Baek SJ, Mays DM, Tithof PK, Eling TE, and Walker NJ (2004) EGR1 is a novel target for AhR agonists in human lung epithelial cells. Toxicol Sci 82:429-435.
22. Matsumura F (1994) How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals? Biochem Pharmacol 48:215-224.
23. Matsumura F (2003) On the significance of the role of cellular stress response reactions in the toxic actions of dioxin. Biochem Pharmacol 66:527-540.
24. Mazina O, Park S, Sano H, Wong P, and Matsumura F (2004) Studies on the mechanism of rapid activation of protein tyrosine phosphorylation activities, particularly c-Src kinase, by TCDD in MCF10A. J Biochem Mol Toxicol 18:313-321.
25. Mufti NA and Shuler ML (1996) Possible role of arachidonic acid in stress-induced cytochrome P450IA1 activity. Biotechnol Prog 12:847-854.
26. Park S, Dong B, and Matsumura F (2007) Rapid activation of c-Src kinase by dioxin is mediated by the Cdc37-HSP90 complex as part of Ah receptor signaling in MCF10A cells. Biochemistry 46:899-908.
27. Park S, Mazina O, Kitagawa A, Wong P, and Matsumura F (2004) TCDD causes suppression of growth and differentiation of MCF10A, human mammary epithelial cells by interfering with their insulin receptor signaling through c-Src kinase and ERK activation. J Biochem Mol Toxicol 18:322-331.
28. Poland A and Knutson JC (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22:517-554.
29. Puga A, Hoffer A, Zhou S, Bohm JM, Leikauf GD, and Shertzer HG (1997) Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol 54:1287-1296.
30. Reiners JJ Jr, Jones CL, Hong N, Clift RE, and Elferink C (1997) Downregulation of aryl hydrocarbon receptor function and cytochrome P450 1A1 induction by expression of Ha-ras oncogenes. Mol Carcinog 19:91-100.
31. Silva CM and Shupnik MA (2007) Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. Mol Endocrinol 21:1499-1512.
32. Singh NP, Nagarkatti M, and Nagarkatti PS (2007) Role of dioxin response element and nuclear factor-κB motifs in 2,3,7,8-tetrachlorodibenzo-p- dioxin-mediated regulation of Fas and Fas ligand expression. Mol Pharmacol 71:145-157.
33. Sun SC, Ganchi PA, Ballard DW, and Greene WC (1993) NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
34. Viu E, Zapata A, Capdevila JL, Fossom LH, Skolnick P, and Trullas R (1998) Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells. J Pharmacol Exp Ther 285:527-532.
35. Yedgar S, Cohen Y, and Shoseyov D (2006) Control of phospholipase A2 activities for the treatment of inflammatory conditions. Biochim Biophys Acta 1761:1373-1382.
36. Yoon CY, Park M, Kim BH, Park JY, Park MS, Jeong YK, Kwon H, Jung HK, Kang H, Lee YS, et al. (2006) Gene expression profile by 2,3,7,8- tetrachlorodibenzo-pdioxin in the liver of wild-type (AhR-/-) and aryl hydrocarbon receptor-deficient (AhR-/-) mice. J Vet Med Sci 68:663-668.